Agios Pharma (AGIO) Tops Q1 EPS by 23c

Agios Pharma (NASDAQ: AGIO) reported Q1 EPS of ($1.55), $0.23 better than the analyst estimate of ($1.78). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $9.97 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBS) Tops Q2 EPS by 24c
• Desjardins Downgrades Alithya Group Inc. (ALYA:CN) (ALYA) to Hold